Overall rank by patents
#28,365
Across all tracked assignees
USPTO PatentsView assignee record - 9 granted patents across 5 technology areas, active 2015–2023. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: C07C (ACYCLIC OR CARBOCYCLIC COMPOUNDS).
The verdict
Chinoin holds 9 US patents across 5 technology areas, rank #28,365 of 50,000 tracked assignees.
Chinoin Gyógyszer És Vegyészeti Termékek Gyára ZRT. has been granted 9 US utility patents between 2015 and 2023, placing Chinoin Gyógyszer És Vegyészeti Termékek Gyára ZRT. at rank #28,365 across all assignees tracked by PlainPatent. This portfolio spans 5 distinct Cooperative Patent Classification (CPC) subclasses, averaging 19.4 claims per patent with primary concentration in C07C (ACYCLIC OR CARBOCYCLIC COMPOUNDS). As a Foreign Corporation, Chinoin Gyógyszer És Vegyészeti Termékek Gyára ZRT. is one of the more focused assignees in the PatentsView dataset. By volume, Chinoin sits between Chengdu Borns Medical Robotics Inc. (9 patents, rank #28,361) and Chongqing Haier Refrigeration Electric Appliance Co., Ltd. (9 patents, rank #28,369) - the closest US assignees by grant volume. The composite Innovation Score of 32.5/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 4 grants, compared with 5 in the 2015–2019 window, a -20% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Chinoin Gyógyszer És Vegyészeti Termékek Gyára ZRT.'s 19.4 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 5 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Chinoin Gyógyszer És Vegyészeti Termékek Gyára ZRT. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
CHENGDU BORNS MEDICAL ROBOTICS INC.
9 patents
CHENGDU HAIGUANG INTEGRATED CIRCUIT DESIGN CO., LTD.
9 patents
CHINA NATIONAL RESEARCH INSTITUTE OF FOOD & FERMENTATION INDUSTRIES CO., LTD.
9 patents
CHINESE PLA GENERAL HOSPITAL
9 patents
CHIPOLO, D.O.O.
9 patents
CHONG CORPORATION
9 patents
CHONGQING ADVANCE DISPLAY TECHNOLOGY RESEARCH
9 patents
CHONGQING HAIER REFRIGERATION ELECTRIC APPLIANCE CO., LTD.
9 patents
CHINOIN GYÓGYSZER ÉS VEGYÉSZETI TERMÉKEK GYÁRA ZRT.
9 patents
What this shows Chinoin holds 9 patents at rank #28,365, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #28,365 in granted patent volume.
Other assignees with the most granted patents in Chinoin's primary technology class.
Chinoin's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
33 Top 58% higher than 42% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 1 | 11.1% |
| 2016 | 1 | 11.1% |
| 2019 | 3 | 33.3% |
| 2021 | 1 | 11.1% |
| 2022 | 2 | 22.2% |
| 2023 | 1 | 11.1% |
Top 5 of 5 technology areas
Overall rank by patents
#28,365
Across all tracked assignees
32.5 out of 100
How to use this portfolio
Chinoin's 9 grants land it in the top 58% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.